Home Cart 0 Sign in  

[ CAS No. 1257704-57-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 1257704-57-6
Chemical Structure| 1257704-57-6
Structure of 1257704-57-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1257704-57-6 ]

Related Doc. of [ 1257704-57-6 ]

Alternatived Products of [ 1257704-57-6 ]

Product Details of [ 1257704-57-6 ]

CAS No. :1257704-57-6 MDL No. :MFCD22683932
Formula : C24H26N6O2S Boiling Point : -
Linear Structure Formula :- InChI Key :RFZKSQIFOZZIAQ-UHFFFAOYSA-N
M.W : 462.57 Pubchem ID :57336812
Synonyms :
Chemical Name :N-(3-(4-Methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine

Calculated chemistry of [ 1257704-57-6 ]

Physicochemical Properties

Num. heavy atoms : 33
Num. arom. heavy atoms : 21
Fraction Csp3 : 0.25
Num. rotatable bonds : 5
Num. H-bond acceptors : 5.0
Num. H-bond donors : 1.0
Molar Refractivity : 137.32
TPSA : 91.22 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.69 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.27
Log Po/w (XLOGP3) : 3.42
Log Po/w (WLOGP) : 3.61
Log Po/w (MLOGP) : 3.3
Log Po/w (SILICOS-IT) : 1.43
Consensus Log Po/w : 3.01

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.0
Solubility : 0.00459 mg/ml ; 0.00000992 mol/l
Class : Moderately soluble
Log S (Ali) : -5.02
Solubility : 0.00446 mg/ml ; 0.00000964 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.14
Solubility : 0.0000333 mg/ml ; 0.0000000719 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.7

Safety of [ 1257704-57-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1257704-57-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1257704-57-6 ]
  • Downstream synthetic route of [ 1257704-57-6 ]

[ 1257704-57-6 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 747413-17-8 ]
  • [ 1257704-13-4 ]
  • [ 1257704-57-6 ]
YieldReaction ConditionsOperation in experiment
0.07 g at 80℃; for 72 h; Inert atmosphere; Sealed tube To an oven dried tube is added palladium acetate (about 10 mg) and 2,2’-bis-dicyclohexylphosphanylbiphenyl(about 30 mg), 8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine (about 75 mg), 1-(3-bromo-phenyl)-4-methylpiperazine (about 80 mg), a suitable base, such as cesium carbonate (about 270 mg) anda suitable solvent, such as 1,4-dioxane (about 5 mL). The tube is evacuated and backflushed with nitrogen threetimes. The tube is sealed and heated at about 80°C for about 72 hours. The mixture is cooled to room temperatureand the product isolated in a suitable manner. For example, the cooled mixture may be diluted with dichloromethane(about 10 mL), filtered through a plug of diatomaceous earth, rinsed with dichloromethane and evaporated. Thematerial may then be purified, e.g., via chromatography, e.g., utilizing an ISCO automated purification apparatus(e.g., amine modified silica gel column 5percent→100percent ethyl acetate in hexanes). [8-(4-Methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine (i.e., COMPOUND A) is isolated as a yellowsolid (about 0.07 g). MP = 232-234 °C. 1H NMR (400 MHz, CDCl3, δ, ppm): 8.49 (d, J=7.2 Hz, 1H), 8.25 (d, J=7.5Hz, 2H), 8.08 (d, J=7.9 Hz, 2H), 7.65 (d, J=7.7 Hz, 1H), 7.38 (s, 1H), 7.27-7.20 (m, 1H), 7.04-6.95 (m, 2H), 6.84 (s,1H), 6.60 (d, J=8.0 Hz, 1H), 3.30-3.25 (m, 4H), 3.10 (s, 3H), 2.63-2.58 (m, 4H), 2.38 (s, 3H). MS = 463 (MH)+
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5243 - 5254
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Patent: EP2648728, 2016, B1, . Location in patent: Paragraph 0047
  • 2
  • [ 13534-99-1 ]
  • [ 1257704-57-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5243 - 5254
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[4] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[5] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[6] Patent: EP2648728, 2016, B1,
  • 3
  • [ 1124382-72-4 ]
  • [ 1257704-57-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2012, vol. 55, # 11, p. 5243 - 5254
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[4] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[5] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
  • 4
  • [ 1124383-00-1 ]
  • [ 1257704-57-6 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[3] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[4] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[5] Patent: EP2648728, 2016, B1,
  • 5
  • [ 149104-88-1 ]
  • [ 1257704-57-6 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
[2] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
  • 6
  • [ 31197-30-5 ]
  • [ 1257704-57-6 ]
Reference: [1] Patent: EP2648728, 2016, B1,
  • 7
  • [ 1257704-13-4 ]
  • [ 1257704-57-6 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
  • 8
  • [ 108-36-1 ]
  • [ 1257704-57-6 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
  • 9
  • [ 109-01-3 ]
  • [ 1257704-57-6 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
  • 10
  • [ 1257706-00-5 ]
  • [ 148546-99-0 ]
  • [ 1257704-57-6 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 12, p. 2085 - 2091
Same Skeleton Products
Historical Records